Affymetrix, a technology developer for technology pharmaceutical, diagnostic, and biotechnology companies, has appointed Timothy Barabe as executive vice president (EVP) and chief financial officer (CFO). Barabe will lead the company’s financial functions as well as the treasury, investor relations, and information technology departments, reporting to Kevin King, president and chief executive officer (CFO). He replaces John Batty, who served three years at Affymetrix and was instrumental in laying the foundation for the company’s long-term growth.
Barabe joins Affymetrix with experience from top-tier pharmaceutical, medical, and emerging life science companies. Since 2006, he served as senior vice president (SVP) and CFO at Human Genome Sciences. Previously, Barabe was CFO at Regent Medical. For more than 20 years, he held senior executive roles in finance, general management, and strategic planning at Novartis, the world’s sixth largest pharmaceutical company. His roles included CFO of the Sandoz Generics Business Unit, president of the CIBA Vision specialty lens business franchise, and group vice president and CFO of CIBA Vision.
Barabe received his MBA in finance from the University of Chicago and his BBA in finance from the University of Massachusetts.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more